The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Oep Ix General Partner L P

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Oep Ix General Partner L P is a private equity based in New York across 125 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Oep Ix General Partner L P on Healthcare.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Oep Ix General Partner L P — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Oep Ix General Partner L P — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Oep Ix General Partner L P — 125
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Oep Ix General Partner L P — Healthcare

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Oep IX General Partner, L.P. — Private Equity · NEW YORK · 125 tracked deals · Oep Ix General Partner L P portfolio

Similar investors

• Thomas S. Giannetti
• Christopher Walsh
• Edward Tsai
• Jin Hing Chin
• Thomas Teles
• Governors Lane Fund General Partner LLC
• Fady Abdel-Nour
• Pete Mathias
• Daniel Fabian
• iCapital Strategies LLC

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Oep Ix General Partner L P · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory